Archives 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 ImmuPharma’s CEO, Tim McCarthy, talks to Proactive Investor and presents the commercial strategy for the Company’s lupus drug Lupuzor™ as FDA approves PK study in advance to starting the Phase 3 trial – 17th August, 2021 17th August 2021 - 3:48 pm Share this article Share on Facebook Share on Twitter
ImmuPharma’s CEO, Tim McCarthy, talks to Proactive Investor and presents the commercial strategy for the Company’s lupus drug Lupuzor™ as FDA approves PK study in advance to starting the Phase 3 trial – 17th August, 2021 17th August 2021 - 3:48 pm
